Half of the plasma samples (50.5%) harbored TP53 mutations, and the frequencies of TP53 mutations were <20% in cervical cancer, gastrointestinal stromal tumors (GIST), thyroid cancer, and melanoma (Fig. 3a). This evidence concerns the gene TP53 and cervical carcinoma.